Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Clinical Study Confirms That EndyMed's New Home Use Device, the Newa, Has Been Proven To Effectively Reduce Wrinkles and Provide Immediate and Long Lasting Facial Lifting
  • USA - English


News provided by

EndyMed Medical, Ltd.

Nov 13, 2014, 03:00 ET

Share this article

Share toX

Share this article

Share toX


Caesarea, Israel (PRWEB) November 13, 2014 -- The Journal of Drugs in Dermatology has published in its November issue a study performed by Neil S. Sadick MD, Yoram Harth MD, Hanna Levy PhD, and Avner Shemer MD, which evaluates and scientifically establishes the efficiency and safety of the Newa Skin Rejuvenation device, a multisource phase-controlled radiofrequency home use device developed by EndyMed Medical that reduces wrinkles and tightens and rejuvenates facial skin.

New at home technologies like the Newa, which is a new generation of skin tightening radiofrequency technology, enables patients and consumers to achieve rejuvenation of the face without going into a doctor’s office..."

Post this

The study published in the JDD this month enrolled 69 participants within the range of 37 – 72 years of age. The participants were provided with the Newa device, together with a user manual and treatment diary, to perform independent treatments at home for 4 weeks. Participants were instructed to perform at least 5 treatments a week for one month. Four follow-up visits were scheduled once a week during the period of independent treatments at home, followed by a 1 month follow-up visit one month after the treatment end, and 3 months follow-up after the end of treatments. Thorough photographic analysis of pre- and post treatment images of the participants measured against the Fitzpatrick Wrinkle and Elastosis Scale was performed by 3 impartial board certified dermatologists. The results of the study revealed a significant improvement in the appearance of wrinkles and skin laxity. Moreover, the participants reported high overall satisfaction with the Newa treatment experience with no side effects or discomfort.

The majority of the study participants stated that they were very satisfied from the results of their Newa treatments. Data taken from the satisfaction questionnaire shows that 86% of participants were satisfied with the Newa device, 93% were satisfied with the safety of performing wrinkle reduction treatments with the Newa, and 90% were satisfied with the ease of the Newa treatments.

Professor Neil Sadick of the Weill Medical College at Cornell University, New York, stated that “New at home technologies like the Newa, which is a new generation of skin tightening radio frequency technology, enables patients and consumers to achieve rejuvenation of the face without going into a doctor’s office or as a maintenance for treatments done in a physician’s setting."

According to Dr. Harth, "Our analysis of the study results showed continued improvement in wrinkle reduction and skin tightening at the 3 month follow-up visit. This indicates that the Newa treatments successfully initiated the natural collagen remodeling process in the skin, which continued well after the treatments were completed."

There have been two previous home use devices that were subjected to clinical study in a controlled setting: one fractional laser device and one tripolar radiofrequency device. However, these studies only tested the effectiveness of the perioral and periorbital areas. This current Newa study is the only home use device study that tested for full face wrinkle reduction and skin tightening.

The demand for non-invasive, long-lasting wrinkle and skin tightening treatments has grown dramatically over the past few decades, and new aesthetic technologies have been used to meet this demand. The main cause of aging skin and wrinkles is the natural reduction and break down in the quantity and quality of the collagen found in the skin as we age.

The first generation of home use devices emitted low intensity red or infrared light or bipolar radiofrequency energy, and delivered only modest improvement in wrinkle reduction or skin texture due to the superficial penetration of energy to the skin. The use of laser based fractional home use devices, recently cleared for treatment of periorbital wrinkles, is frequently limited by small treatment areas, pain, and skin type. The Newa, representing the next generation of home use treatment devices, is not limited by treatment areas. The Newa has been proven effective for full face wrinkle reduction, and provides a safe, pain free and pleasant treatment experience.

Radiofrequency-based treatments have been shown to be clinically effective as a non-invasive treatment technology to reduce wrinkles and tighten skin on the face, neck, and body. EndyMed Medical, one of the premier developers of radiofrequency aesthetic treatment systems, utilizes its innovative 3DEEP® radiofrequency technology within its treatment systems. Unlike most radiofrequency technologies that use just 1 radiofrequency generator in their systems, EndyMed's 3DEEP technology uses a unique system of 6 RF generators that provides the most effective, deep and focused RF treatment available today. EndyMed's 3DEEP technology has been used in thousands of professional aesthetic treatments in dermatological clinics internationally and utilizes a downsized version of it for use in their new home use treatment device, the Newa, which is FDA cleared for the home use market.

About EndyMed Medical
EndyMed Medical Ltd., established in 2007, offers energy based aesthetic treatment systems for the professional and home use markets. EndyMed's proprietary 3DEEP® radiofrequency technology is a unique solution for non-invasive, fractional and non-ablative wrinkle treatment, skin tightening on both the face and body, body contouring and acne scar treatment. Through the three dimensional interaction of multiple RF sources, 3DEEP® RF creates deep thermal patterns in the tissue which is a novel and effective approach to aesthetic treatments. For more information, please see our website at http://www.endymed.com.

Tammy Weisman Maman, EndyMed Medical, Ltd., http://www.endymed.com, +972 577750036, [email protected]

Modal title

The Newa Skin Rejuvenation Device and Activator Gel
The Newa Skin Rejuvenation Device and Activator Gel
The Newa Skin Rejuvenation System
The Newa Skin Rejuvenation System
The Newa Skin Rejuvenation Device and Skin Care Line
The Newa Skin Rejuvenation Device and Skin Care Line
The Newa Skin Rejuvenation Device and Activator Gel The Newa Skin Rejuvenation System The Newa Skin Rejuvenation Device and Skin Care Line

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.